Skip to main content
. Author manuscript; available in PMC: 2010 Dec 18.
Published in final edited form as: Transplantation. 1995 Jul 27;60(2):158–171. doi: 10.1097/00007890-199507000-00009

Table 3.

Chimerism in BN recipients 30 and 100 days after transplantation of LEW organs or leukocyte suspensions under a short course of tacrolimusa

30 Days
100 Days
Flow cytometry (class I)b Immunohistochemistry (class II)c Lineage Immunocytochemistry (class II)e Tolerance GVHD
Small bowel 4.0±2.3%d + + + T > Me No 100%
Lymph nodes 4.1±1.8% + + + T > M No 100%
Spleen 7.5±0.2% + + + T > M Minimalf 100%
Liver <1.0% + + M = T ± Yes 0
Bone marrow 0 + M > T ± Yes 0
Heart 0 ± Partialg 0
Kidney NT ± NT 0
Thymus NT No 0
Blood NT No 0
a

1.0 mg/kg/day on days 0 to 13; 20, and 27.

b

McAb 163, blood samples, or recipient lymph node suspensions.

c

L-21-6Ab, spleen, and cervical lymph nodes.

d

Mean ± SD.

e

NT: not tested; M: multilineage; T: T lymphocyte.

f

Delayed acute rejection.

g

Chronic rejection.